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Aim
To compare the in vitro secretion of IL-1β in patients car-
rying CIAS-1 mutations and TRAPS patients, in an effort
to understand the mechanism modulating IL-1β secretion
in the different pathologies responding to anti IL-1 treat-
ment.
Methods
Monocytes from 6 CINCA and 4 TRAPS patients selected
for treatment with Anakinra were activated with 1 μg/ml
of LPS for 3 hours, at baseline and after 7 days from the
beginning of the treatment. For comparison, monocytes
from 24 healthy donors were also studied. Intracellular
pro-IL-1β and secreted IL-1β were analysed by Western
blotting and ELISA before and after a short exposure (15
min) to exogenous ATP that accelerates IL-1β secretion.
Results
In healthy subjects LPS-induced IL-1β secretion was varia-
ble but consistently ≤5 ng/ml and it was markedly
increased by exposure to exogenous ATP (up to 20 ng/ml).
Monocytes from CINCA patients secreted abnormally ele-
vated amounts of IL-1β after LPS stimulation (up to 40
ng/ml) that were not increased by ATP. Conversely,
monocytes from TRAPS patients did not secrete more IL-
1β than healthy controls in response to LPS, but similarly
to CINCA patients presented a low response to ATP.
Conclusion
Despite a similar clinical response to anti-IL1 treatment,
the pattern of IL-1β secretion of monocytes from Anak-
inra-responder TRAPS patients significantly differ from
that observed in patients CIAS-1 mutations. This study
suggests a different hierarchy in the pathogenic mecha-
nisms leading to the inflammatory response in different
diseases responsive to anti-IL-1 treatment.
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